Diane C. McEnroe

Diane’s most recent speaking engagements include:

Presenter, “Minimizing Risk by Maximizing Cross-Departmental Collaboration in Marketing and Advertising: How to Get Ahead of an Issue before it Starts,” 4th Annual Momentum Food & Beverage Litigation, Compliance & Regulatory Exchange (September 29–30, 2016).

Presenter, “Claim Substantiation for Food and Dietary Supplements,” FDLI, Food Advertising, Labeling and Litigation Conference (Washington, D.C., September 14–15, 2016).

Presenter, “Cosmetic Labeling 101,” National Product’s Association’s Webinar Series (August 24, 2016).

Presenter, “Backing the Proofs of Your Promotional Activities: Structuring Claim Substantiation in the Face of New FTC and NAD Activities” and “Claims Substantiation Master Class,” American Conference Institute, 4th Annual Legal, Regulatory and Compliance Forum on Dietary Supplements (June 27–28, 2016).

Presenter, “OTC Post-Market Considerations: Adverse Events, Safety Communications and Label Warnings,” American Conference Institute, Advanced Legal, Regulatory and Compliance Forum on OTC Drugs (October 30, 2015).

Presenter, “Thinking Outside the Box: How to Utilize Market Actions to Moot Class Action Claims in Real Time” and “Focus on Social & Digital Media: Food & Beverage Industry Concepts for Innovative Marketing & Advertising Campaigns,” 3rd Annual Momentum Food & Beverage Litigation, Compliance & Regulatory Exchange (October 28, 2015).

Presenter, “Cosmetic Compliance: Don’t Get Sacked in a Warning Letter Blitz,” Natural Product’s Association’s Webinar Series (May 20, 2015.)

Presenter, “Life Sciences College: U.S. Pharmaceutical, Biotechnology and Medical Device Regulatory, Compliance and Corporate Update,” Sidley Austin LLP (New York, NY, April 2014).

Product Positioning for Food and Supplements: Strategies for Minimizing Regulatory and Litigation Attacks” webinar (December 4, 2012).

Co-Chair of The Legal, Regulatory and Compliance Forum on Over-the-Counter Drugs, American Conference Institute (2012, 2013 and 2014), and presented “OTCs and Consumer Health Products 101: Defining, Establishing and Perfecting OTC-Ness” and “Define, Distinguish and Differentiate: Best Practices for Adverse Event Reporting on Non-Prescription Drug Products” (October 17–19, 2012).

Panelist, “U.S. & Brazil: Navigating New Frontiers in Pharmaceutical, Medical Device and Food Law & Regulation,” Food and Drug Law Institute (FDLI) Conference (São Paulo, Brazil, September 10–11, 2012).

The Federal Trade Commission and the Regulation of Medical Devices,” Advanced Medical Technology Association (AdvaMed) meeting on “Advertising and Promotion of Medical Devices in an Age of DTC and Social Media Marketing” (Washington, D.C., 2011).

Presenter, Basics of Food and Dietary Supplement Labeling, Introduction to Food Law and Regulation, The Food and Drug Law Institute (Washington, D.C., January 22, 2008).

Presenter, N.Y. State Food, Drug, and Cosmetic Law Section, Annual Meetings (January 2005 and January 2007).

Diane works with The Alliance of African Shea Associations, which represents shea producers in Ghana, Nigeria, Burkina Faso, Mali, Benin and Côte d’Ivoire, assisting the Alliance in accessing the U.S. chocolate market and with efforts to permit the use of shea butter as an equivalent ingredient to cocoa butter. The goal of this pro bono initiative is to enhance the incomes of approximately four million women farmers who collect shea nuts in West Africa.

Diane also supports the Sidley Emerging Enterprises Pro Bono Program. Here, the firm provides international trade advice to the Bangladesh Shrimp and Fish Foundation, which represents some 600,000 shrimp farmers in Bangladesh who primarily export to the EU and the U.S.

Co-author with Scott Bass, Sarah Goldstein and Emily Marden “FDA’s Final Medical Foods Guidance Maintains Restrictions on Category,” International Law Office (2016).

Chapters on “Regulatory Status and Formulation” (with Scott Bass), “Product Claims and Intended Use” (with Nick Wimbush), “Dietary Supplement Labeling” (with Scott Bass and Nick Wimbush), and “Dietary Supplement Safety” (with multiple co-authors), Dietary Supplement Regulation: A Comprehensive Guide,Food and Drug Law Institute (2011).

Co-author with Paul E. Kalb, Karen O. Dunlop and Scott Stein “Analyzing the Laws, Regulations, and Policies, Affecting FDA-Regulated Products, Direct-to-Consumer Marketing: The Food and Drug Administration Is Not Alone,” Food and Drug Law Journal (2003).